Immunohistochemical imaging of ERs, progesterone receptors (PRs) and human epidermal growth factor receptors (HER2s) in breast cancers provided further possibilities to clarify the risk factors and therapeutic possibilities of variously differentiated tumors (29). The gene discussed is PGR; the disease is breast carcinoma.